Searched for
G. V. PRASAD
Congress weighs CM choice after UDF’s landslide win in KeralaKerala witnesses a significant political shift as the Congress-led UDF returns to power after a decade. Discussions are underway to select ...- Kerala Election Results 2026: Check full list of winning candidatesEarly trends from Kerala Assembly elections show the United Democratic Front (UDF) taking a strong lead. The Indian National Congress is pe...
- Nemom Election Results 2026: BJP, Congress, CPI(M) lock horns as Chandrasekhar goes against Sabarinadhan, SivankuttyNemom, a key Thiruvananthapuram suburb, faces a crucial 2026 Assembly election. This suburban seat blends urban growth with traditional are...
- Kerala Election Winners List 2026: Check the full party-wise candidates winner listThe Congress-led UDF has secured a significant victory in Kerala. This marks the end of ten years of Left rule in the state. The list of wi...
- Karnataka 2nd PUC Result Toppers list 2026: Check the top rank holders' names, scores in Arts, Science and Commerce streamsThe Karnataka School Examination and Assessment Board (KSEAB) is set to release the 2nd PUC toppers list for arts, science, and commerce st...
- Chiranjeevi’s Mana Shankara Vara Prasad Garu and Naveen Polishetty’s Anaganaga Oka Raju OTT releases on same day: When and where to watch onlineChiranjeevi's Mana Shankara Vara Prasad Garu and Naveen Polishetty's Anaganaga Oka Raju, released during Sankranthi 2026, are now streaming...
- Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine“The Indian clinical trial being conducted by Dr Reddy’s and RDIF is an adaptive design phase 2/3 trial. It is a bridging study to the larg...
- COAI seeks urgent allocation of E and V band spectrum via auction to access providersIn a letter to Communications Minister Ravi Shankar Prasad, the Cellular Operators' Association of India (COAI) on Monday called for alloca...
- Dr Reddy's completes the acquisition of Wockhardt's select generics, plantG V Prasad, Co-Chairman and Managing Director of Dr. Reddys said this deal is in line with the companys strategic focus on India and has pa...
- Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-endUSFDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice deviations at DR Reddy's API manufacturing...
- Dr Reddy's sells two neurology products in $110 mn dealDr Reddy's will receive $ 70 mn as upfront consideration, $40.5 mn in near-term milestones.
- Dr Reddy's subsidiary sells, assigns US rights for 3 brands to Encore DermatologyCEO G V Prasad said the announcement is in line with its renewed strategy to enable us achieve self-sustainability
- Amazing opportunities for start-ups in heatlh care: GV PrasadPrasad said great progress is likely to be achieved in the next 10-15 years in the field of cancer treatment with the evolution of new trea...
- Buy Dr. Reddy's Laboratories, target Rs 2715.0 : Siddharth BhamreBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 2715.0 and a stop loss at Rs 2560.0 from entry point
- Sell Dr. Reddy's Laboratories, target Rs 2577.0 : Deen Dayal InvestmentSell Dr. Reddy's Laboratories Ltd. at a price target of Rs 2577.0 and a stop loss at Rs 2650 from entry point
- Dr Reddy's to invest in startupsDr Reddy's Laboratories (DRL) will be investing in startups besides partnering with external entities for research and innovation.
- Dr Reddy's Laboratories continues to see huge selling, down over 5%Dr Reddy's Lab continued to face selling pressure for a third straight session today on receiving a warning letter from the US drug regulat...
- India should allow entry of international education institutes: G V PrasadIndia should allow international educational institutes to operate in India, G V Prasad, co-chairman and CEO of DR Reddy's Lab, said.
- Dr Reddy's Laboratories to acquire OctoPlus NV for 27.39 million eurosDr Reddy’s Labs has agreed to buy the entire equity holding of OctoPlus NV for 27.39 million euros (Rs 191.72 crore) in an all cash deal.
- Growth rates may decline in next few years: Dr Reddy's LaboratoriesDr Reddy's Laboratories today said its growth rates are likely to decline in the next few years due to expiry of many of its patents.
Load More
